A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT 1 receptors

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

(2017) Paul K. Whelton et al.   HYPERTENSION

Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

(2017) Bin Zhou et al.   LANCET

Development of Safe Drugs: The hERG Challenge

(2017) Subha Kalyaanamoorthy et al.   MEDICINAL RESEARCH REVIEWS

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

(2017) Simon D Harding et al.   NUCLEIC ACIDS RESEARCH

Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine

(2017) Xiajun Hu et al.   Scientific Reports

Follicular Helper T Cells

(2016) Carola G. Vinuesa et al.   Annual Review of Immunology

Global Disparities of Hypertension Prevalence and ControlClinical Perspective

(2016) Katherine T. Mills et al.   CIRCULATION

Epigenetic regulation of L-type voltage-gated Ca2+ channels in mesenteric arteries of aging hypertensive rats

(2016) Jingwen Liao et al.   HYPERTENSION RESEARCH

ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice

(2016) Yanzhao Zhou et al.   JOURNAL OF HYPERTENSION

Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs

(2016) Lin Tang et al.   NATURE

TRPC5 channels participate in pressure-sensing in aortic baroreceptors

(2016) On-Chai Lau et al.   Nature Communications

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP

(2015) John C McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

New Approaches in the Treatment of Hypertension

(2015) S. Oparil et al.   CIRCULATION RESEARCH

Long-term use of angiotensin II receptor antagonists and calcium-channel antagonists in Algerian hypertensive patients: Effects on metabolic and oxidative parameters

(2015) Chafika El Hassar et al.   FREE RADICAL BIOLOGY AND MEDICINE

Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive RatsNovelty and Significance

(2015) Hiroshi Koriyama et al.   HYPERTENSION

Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy

(2015) Dan Ding et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments

(2015) John Foerster et al.   Nanomedicine

Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery

(2015) Yuan Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis

(2015) Xin-Fang Leong et al.   Biomed Research International

L-Type CaV1.2 Calcium Channels: From In Vitro Findings to In Vivo Function

(2014) Franz Hofmann et al.   PHYSIOLOGICAL REVIEWS

Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension

(2014) Quynh N. Dinh et al.   Biomed Research International

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

(2014)   Lancet Diabetes & Endocrinology

Anti-KCNQ1 K+ channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy

(2013) Jin Li et al.   CARDIOVASCULAR RESEARCH

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

Hepatitis B core–based virus–like particles to present heterologous epitopes

(2013) Kenny Roose et al.   Expert Review of Vaccines

Provocation of an Autoimmune Response to Cardiac Voltage-Gated Sodium Channel NaV1.5 Induces Cardiac Conduction Defects in Rats

(2013) Sevil Korkmaz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effectiveness and Safety of a Therapeutic Vaccine Against Angiotensin II Receptor Type 1 in Hypertensive Animals

(2012) Xiao Chen et al.   HYPERTENSION

Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome

(2011) Roberto Fogari et al.   HYPERTENSION RESEARCH

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies

(2010) Andrea Jegerlehner et al.   VACCINE

Glycoconjugate vaccines and immune interference: A review

(2010) Ron Dagan et al.   VACCINE

Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

(2009) David S. Wald et al.   AMERICAN JOURNAL OF MEDICINE

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

(2008) Alain C Tissot et al.   LANCET

Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein

(2008) Aric L. Gregson et al.   PLoS One

Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo

(2008) Y. J. Liao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA